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Abstract
Positron emission tomography (PET) is a molecular medical imaging
modality which is commonly used for neurodegenerative disease diagnosis.
Computer-aided diagnosis (CAD), based on medical image analysis, could help
with the quantitative evaluation of brain diseases such as Alzheimer’s disease (AD).
Ranking the effectiveness of brain volume of interest (VOI) to separate healthy or
normal control (HC or NC) from AD brain PET images is presented in this book
chapter. Brain images are first mapped into anatomical VOIs using an atlas.
Different features including statistical, graph, or connectivity-based features are
then computed on these VOIs. Top-ranked VOIs are then input into a support
vector machine (SVM) classifier. The developed methods are evaluated on a local
database image as well as on Alzheimer’s Disease Neuroimaging Initiative (ADNI)
public database and then compared to known selection feature methods. These
new approaches outperformed classification results in the case of a two-group
separation.
Keywords: machine learning, computer-aided diagnosis, first order statistics,
feature selection, positron emission tomography, classification, Alzheimer’s disease
1. Introduction
Alzheimer’s disease (AD) is a degenerative and incurable brain disease which is
considered the main cause of dementia in elderly people worldwide. At present,
there are around 90 million people who have been diagnosed with AD, and it is
estimated that the number of AD patients will reach 300 million by 2050 [1, 2]. The
diagnosis of this disease is done by clinical, neuroimaging, and neuropsychological
assessments. Neuroimaging evaluation is based on nonspecific features such as
cerebral atrophy, which appears very late in the progression of the disease.
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Advances in neuroimaging biomarkers help to identify AD in its prodromal
stage, mild cognitive impairment (MCI) [3]. Therefore, developing new approaches
for early and specific recognition of AD is of crucial importance [4]. Positron
emission tomography (PET) is nowadays widely used in neuroscience to
characterize brain molecular mechanisms involved in healthy and pathological
models [5]. Applied to the brain, PET imaging provides a noninvasive evaluation of
various biomarkers, such as the metabolic rate of glucose, the cerebral blood flow,
and the neurotransmission, but also the evaluation of some pathological processes
such as the neuroinflammation, amyloid deposits, and more recently tubulin-
associated unit (TAU) aggregates. In this line, PET using 18-fluoro-deoxy-glucose
(18FDG) has been proposed as a biomarker of Alzheimer’s disease [6–10].
18F-FDG-PET provides 3D-volumetric brain imaging of the cerebral metabolic
rate of glucose, thought to reflect the synaptic activity and thus the functional
brain. However, these abnormalities, evident on average within a group of patients,
or in individual cases with advanced disease, can be individually more difficult to
confirm in a purely visual interpretation, particularly in the earliest stages of the
disease when the current treatment (and those under development) would be yet
the most effective. This visual interpretation is in addition subjective and also
highly impacted by the experience of the physician. Individual, quantitative, and
computer-aided approaches are thus needed for medical management of brain
diseases. There has been a growing interest in using the cerebral glucose
metabolism rate for AD classification and prediction of conversion from MCI to
AD [11–13]. Four main groups of methods have been studied: voxels as feature
(VAF)-based [14], discriminative voxel selection-based [15, 16], atlas-based
[17–20], and projection-based methods [21]. Recently deep learning and more
specifically convolutional neural networks (CNN) and recurrent neural networks
(RNN) have been investigated for image classification in the case of Alzheimer’s
disease computer-aided diagnosis. These approaches show better results than
many of the machine learning techniques that have been proposed for recognition
tasks [22–27].
In this chapter, a description on the main steps of a computer-aided diagnosis
system for AD based on 18F-FDG-PET brain images is given. Section 2 is devoted to
data acquisition and preprocessing. Section 3 describes computed features extracted
from brain PET images. A feature selection description is reported in Section 4.
In Section 5 classification step is explained. Finally a conclusion and future work
are given.
2. Materials and methods
2.1 Overview of the computer-aided diagnosis system
A computer-aided diagnosis (CAD) (see Figure 1) system consists in different
important stages including image acquisition and preprocessing, feature extraction,
feature selection, and classification.
In this chapter, the described CAD system focuses on 18F-FDG-PET images
from local and public databases and is atlas-based. This means that each PET brain
image is mapped into anatomical volume of interests (VOIs), on which features are
extracted and then input to a classifier, instead of inputting the whole voxels of each
brain image. The goal of such a system is to provide doctors with tools that help
them to classify AD and HC subjects.
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2.2 Image dataset and preprocessing
2.2.1 Image dataset
Two datasets are presented in this chapter and used to evaluate the two
approaches described in the following. The local database (Table 1) consists in
18F-FDG-PET scans that were collected from the “La Timone” University
Hospital, in the Nuclear Medicine Department (Marseille, France). The local
database image enrolled 171 adults 50–90 years of age, including 81 patients with
AD and 61 health control (HC) and 29 mild cognitive impairment (MCI). HC were
free from neurological/psychiatric disease and cognitive complaints and had a
normal brain MRI. AD subjects exhibited NINCDS-ADRDA [28] clinical criteria for
probable AD.
HC AD MCI
Number 61 81 29
Male/female (24/37) (32/49) (12/17)
Ages (Mean [Min.Max]) 68.18 [50.86] 70.60 [50.90] 67.55 [50.85]
Table 1.
Demographic and clinical information of subjects of the local database.
Characteristic HC AD MCI
Number of subjects 90 94 88
Female/male 34/56 38/56 32/56
Age (Mean  SD) 76.08  5.01 75.83  7.37 76.71  6.63
MMSE (Mean SD) 23.46  2.14 28.97  1.15 26.92  1.62
Table 2.
Demographic and clinical information of subjects of ADNI database.
Figure 1.
Flowchart of a CAD system.
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The second used dataset (Table 2) was obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was
launched in 2003 as a public-private partnership, led by Principal Investigator
Michael W. Weiner, MD. The primary goal of ADNI has been to test whether serial
MRI, PET, other biological markers, and clinical and neuropsychological assessment
can be combined to measure the progression of MCI and early AD.
Therefore, 272 post-processed baseline FDG-PET data were obtained from
ADNI, including 94 subjects with AD, 88 subjects with MCI, and 90 NC subjects.
2.2.2 Image preprocessing
Image comparison with brains from different subjects is difficult due to the
complexity and anatomical variations of brain structures. For that purpose image
data were preprocessed into three steps: spatial normalization, smoothing, and
intensity normalization. Spatial normalization was done by registration at voxel
level using SPM8 software [11]. The data was spatially normalized onto the Mon-
treal Neurological Institute atlas (MNI). These images were then smoothed using a
Gaussian filter with an 8 mm full width at half maximum (FWHM) to increase the
signal-to-noise ratio (SNR) [20]. After spatial normalization, intensity normaliza-
tion was required in order to perform direct image comparison between different
subjects. It consisted in dividing the intensity level of each voxel by the intensity
level mean of the brain’s global gray matter VOI.
2.3 Feature extraction
Each 3D PET brain image was segmented into 116 volumes of interest (VOIs)
using an automated anatomical labeling (AAL) atlas. In this research project, the
ability of VOIs to best distinguish AD from HC subjects was studied. Different
parameter combinations for each VOI were used to select and rank VOIs according
to their ability to separate AD group from HC one. The top-ranked VOIs were then
introduced into a classifier. Several levels of features were extracted from VOIs.
Two approaches have been investigated to achieve this goal.
2.3.1 Separation power factor
In the first approach, only features that extract the statistical information from
each VOI are computed. First order statistics and the entropy are extracted from the
histogram h(x) of each VOI:
h xð Þ ¼
number of voxels in a given ROI with grel level x
total number of pixels in the given ROI
(1)
where x is a gray-level value of a voxel belonging to a VOI and lmin and lmax are









2h xð Þ Variance (3)
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h xð Þ log 2 h xð Þð Þ Entropy (5)
For a given VOI, we compute a set of parameter values {Pp|pϵ {1…K}} = {P1, P2,
P3, P4, P5}. For easier readability, {Pp} is used instead of {Pp|pϵ {1…K}} in the
following. HC and AD subjects are plotted in a N feature space, which represents a
subset of {Pp}, denoted {Pp}N, N ≤ K among subsets. N-Dimensional sphere (N-D
sphere) is created over the group of healthy subjects (HC) (N of length one
correspond to an interval, N of length two correspond to a disk, N of length greater
than or equal to three correspond to a sphere). The N-D sphere’s center is the mass
center of healthy subjects’ distribution. Figure 2 shows the case of a VOI based on
three parameters: the mean, P1; the standard deviation, P2; and the kurtosis, P4. It is
a 3D sphere with N = {P1, P2, P4}. At various radii of the N-D sphere, we compute
the true positives (TPR) and the false positive rates (FPR).
The ROC curve is created by plotting the true positive rate (TPR) vs. the false
positive rate (FPR) for different radii of the N-D sphere settings as it is shown in
Figure 3. The SPF is defined as the area under the ROC curve (AUC) and is within
the range [0, 1].
2.3.1.1 “Combination matrix” analysis
SPF is taken as a key factor to build “combination matrix.” For each VOI, we
compute this factor all over the combinations of parameter Pp with a length varying
from 1 to K (number of feature parameters K = 5). “Combination matrix” is then
built and contains 2K1 columns.
Each line of this matrix represents a VOI, and each column represents the
SPF (noted αvN or αv{Pp}N) computed on a subset {Pp}N of N elements of {Pp}.
Figure 2.
The separation between AD and HC groups relative to the region “Cingulum_Post_Left” with three parameters:
the mean, the standard deviation, and the kurtosis.
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The “combination matrix” has then L lines and 2K1 columns. L = 116 is the
number of VOIs.
2.3.1.2 “Combination matrix” 1: mono-parametric analysis
Mono-parametric analysis consists in ranking VOIs according to their higher
values of SPF in the “combination matrix.” The set of the top-ranked VOIs are
selected for the classification step.
2.3.1.3 “Combination matrix” 2: multi-parametric analysis
Multi-parametric analysis for “combination matrix” depends on both the com-
bination of the parameters (subset of {Pp}) for each VOI and the combination of the
VOIs, subsets of {Vv,|vϵ {1… L}}.
The procedure begins with the choice of the first two combination VOIs
depending on all the possible combinations of VOIs of length 2 ({Vj, Vq}, 1 ≤ j,
q ≤ L, j 6¼ q). Thereafter, it consists on an iterative process according to which we
add one VOI at each step to a VOIs list, sequential forward selection (SFS) [29].
At each step of the iterative procedure, HC and AD subjects are plotted in a new
feature space by combination of parameters for that selection of VOIs, and examine
the SPF value based on this combination, which is named cumulated CSPF. The
VOIs that provide the best cumulated SPF value are then added to the final VOI
combination. Our algorithm stops when the same or a lower cumulated SPF is
obtained.
2.3.2 Multilevel representation
In the second approach, we investigate the multilevel feature representation,
which considers both region properties (first level), connectivity between any pair
Figure 3.
ROC curve obtained for the region “Cingulum_Post_Left” using three parameters: the mean, the standard
deviation, and the kurtosis.
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of VOIs (second level), and an overall connectivity between one region and the
other regions (third level). The proposed method ranks regions from highly to
slightly affected by the disease. A classifier selection strategy is proposed to choose a
pair of classifiers with high diversity.
2.3.2.1 First-level feature
The first-level feature consists in computing the first order statistics of voxels



















where rmn and r
s
n are the mean intensity and standard deviation of each VOI,
respectively, and p is the number of VOIs; here p = 116.
2.3.2.2 Second-level feature
The second-level feature consists in computing a similarity-based connectivity





0 i ¼ j
8<
: (6)
where xi is the feature vector containing the mean and standard deviation of the
ith VOI and wij is the similarity coefficient between the ith and the jth VOIs. The
second-level features of any subject is denoted Wr which is a symmetric matrix.
The second-level feature is composed of similarity coefficients between all the
116 VOIs, totally 6670 dimension (upper part of matrixWr), which is clearly not an
optimal dimension for the subsequent classification. Therefore,Wr is further
decomposed into three subsets of features. Similar to the way of computing simi-
larity coefficients between VOIs, we can obtain similarity coefficients between




0 u ¼ v
(
(7)
where u and v stand for the uth and vth subjects. For any VOI, a symmetric
matrix for subjects,Ws is computed.
The dimension ofWs is determined by the number of subjects, N, in a group
(AD, NC, MCI). Since each subject is segmented into 116 VOIs, thus there are 116
matrices likeWs.
On the one hand, a VOI that is not affected by AD will give similar coefficients
between AD and NC subjects. On the other hand, a VOI affected by AD will give
different similarity coefficients for the two groups. In order to quantify the differ-
ence, we compute the frequency distribution histogram of the upper triangle values
ofWs. Figure 4 shows the cumulative probability curve of similarity coefficients
obtained for region angular L (c), region hippocampus L (b), and region cerebellum
10 R (a), respectively. There is a clear difference between the AD and NC groups in
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Figure 4a, and for the other two VOIs, the difference decreases gradually. Cerebel-
lum 10 R appears as the VOI that is almost unaffected by AD, while VOI angular L is
the one that is most affected by AD. The area under curve, denoted S, quantifies
differences between VOIs.
After ranking all the VOIs, the similarity matrixWr is recalculated according to
the new order of VOIs.Wr is divided into four equal parts, as shown in Figure 5a.
VOIs that are highly involved in AD appear in red and are denotedWh. VOIs that
are less involved in AD appear in blue and are denotedWl. Connectivities between
highly and slightly influenced VOIs, denotedWm, appear in green.
Since Wr is symmetric, only upper triangular matrix is taken into consideration,
like in Figure 5b. Therefore, the second-level featureWr is divided into three sets,
and after converting them to vectors, the second-level feature for the nth sample is
represented as whn, w
m
n , and w
l




n (red and blue parts in
Figure 5b), the dimension is 1653 (58 (58–1)/2), and for wmn (green part), it is
3364 (58  58). Apparently, compared to 6670 (red, blue, and green parts), the
dimension is decreased by about 50–75%.
2.3.2.3 Third-level feature
The third-level feature is extracted from a graph, which represents the overall
connectivity between a VOI and the others. A graph G = (V, E) is defined by a finite
Figure 4.
Statistics of the similarity coefficients between subjects for certain VOIs. (a) VOI: angular L; (b) VOI:
hippocampus L; (c) VOI: cerebellum 10 R.
Figure 5.
Instance of the division for a similarity matrix. Highly involved VOIs in AD (red); Less involved VOIs in AD
(blue); Connectivities between highly and slightly influenced VOIs appear in green.
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set V of vertices (VOIs) and a finite set E ⊆ V  V of edges (similarity coefficient
between the ith and the jth VOI is denoted αij).
After constructing a graph for a subject, several graph measures can be com-
puted [30]. The third-level feature is represented by two graph measures: strength
and clustering coefficient.





where si is the strength of a vertex or a VOI.







d d 1ð Þ
(9)
where diag() is an operator which takes the diagonal values from a matrix, c is a





where aij is the connection status between the ith vertex and the jth vertex:
aij = 0 when wij = 0, otherwise aij = 1.
These features exhibit different ranges of values. Thus a procedure of feature





where fmn is the value of the mth feature of the nth sample and μm and δm are the
mean value and standard deviation of the mth feature, respectively. Most of the fmn
values are within the range [1, 1], while out-of-range values are clamped to either
1 or 1.
2.4 Classification results
2.4.1 Separation power factor approach
Classification was performed using a support vector machine (SVM) classifier.
These classifiers map pattern vectors to a high-dimensional feature space where a
“best” separating hyperplane (the maximal margin hyperplane) is build. In the
present work, we used a linear kernel SVM classifier [29]. The reduced number of
subjects (142 patients) for this first approach leads to use a leave-one-out (LOO)
strategy as the most suitable for classification validation. This technique iteratively
holds out a subject for test while training the classifier with the remaining subjects, so
that each subject is left out once. Parameter C is used during the training phase and
tells how much outliers are taken into account in calculating support vectors. A good
way to estimate the better C value to be used is to perform it with cross-validation. As
result, the estimation value is fixed to 10 (C = 10) depend upon database.
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The results achieved using the proposed method with SVM are shown in
Figure 6. These results are compared to different feature selection methods: Fisher
score [31], support vector machine-recursive feature elimination (SVM-RFE) [32],
feature selection with random forest [33], ReliefF [34], and minimum redundancy
maximum relevance (mRMR) [35]. Cross-validation average accuracy results are
shown as a function of the number of selected VOIs. We note that by injecting 19,
20, or 21 VOIs with their combination of parameters in the SVM with “combination
matrix” 1, mono-parametric analysis, we obtain a classification rate of 95.07%. The
“combination matrix” 2 achieved higher accuracy with lower number of features
(14 VOIs). The best classification results were obtained on the “combination
matrix” 2, achieving 96.47%. Therefore, the proposed feature selection from PET
images is very effective providing a good discrimination between AD subjects and
HC, where we considered the VOIS in the brain image illustrated in Figure 7.
2.4.2 Multilevel approach
The support vector machine (SVM) classifier was also applied in this second
approach for classifying AD or MCI from NC subjects. This second approach takes
into account three levels of features, the total of which is seven types of features
that are input to seven linear SVMs. The margin parameter C of all the SVMs is
fixed to one for a fair comparison. The final decision is made through a majority
voting of the seven classifiers’ outputs:






where sgn() is a sign function and yt denotes the labels of SVMt.
Classification concerns AD vs. NC and MCI vs. NC. Evaluation was done using
four different parameters: classification accuracy (ACC), sensitivity (SEN), speci-
ficity (SPE), and area under the curve (AUC). A tenfold cross-validation technique
Figure 6.
Average accuracy obtained with SVM classifier varying number of features for different VOI selection analyses
and applying LOO cross-validation with estimation value C = 10.
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Figure 7.
15 VOIs’ representation of the “combination matrix” 2 on a coronal plane (a), on a transverse plane (b), and
on a sagittal plane (c).
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was used to assess the performance and repeated 10 times to reduce the possible
bias. A least absolute shrinkage and selection operator (LASSO) was used for fea-
ture selection. LASSO parameter λ retained for the experiments was obtained by
nested cross-validation on the training dataset. Tables 3 and 4 show the obtained
results for AD vs. NC and MCI vs. NC when using each feature, respectively. As can
be seen, the first-level and second-level features outperformed the third-level fea-
ture for AD and MCI diagnosis. This could be explained since the two first-level
features are more linked to VOI’s property or connectivity between each pair of
VOIs, while the third-level feature represents an overall connectivity between a
VOI and the others.
This second proposed method was compared with the state-of-the-art methods,
including Hinrichs’s method [14], Gray’s method [12], Li’s method [36], and
Padilla’s method [21], which were applied to FDG-PET data. The results are shown
Feature ACC SEN SPE AUC
Mean intensity 85.13 86.61 83.97 93.39
Standard deviation 85.49 84.98 86.24 93.84
Connectivity wh 85.05 86.24 84.56 93.01
Connectivity wm 86.88 88.82 85.17 93.88
Connectivity wl 83.98 84.31 83.37 91.37
Strength 80.77 80.29 81.50 88.63
Clustering coefficient 83.89 84.03 84.26 92.05
Table 3.
Performance of different types of feature for AD vs. NC (%).
Feature ACC SEN SPE AUC
Mean intensity 73.55 75.01 72.87 81.36
Standard deviation 78.19 78.31 78.69 86.67
Connectivity wh 72.78 70.63 74.35 83.19
Connectivity wm 74.67 76.06 73.65 83.27
Connectivity wl 74.89 77.01 72.68 78.94
Strength 71.72 70.62 72.01 80.07
Clustering coefficient 72.31 74.73 70.26 80.36
Table 4.
Performance of different types of feature for MCI vs. NC (%).
Method ACC SEN SPE AUC
Hinrichs et al. [14] 84 84 82 87.16
Gray et al. [12] 88.4 83.2 93.6 —
Li et al. [36] 89.1 92 86 97
Padilla et al. [21] 86.59 87.50 85.36 —
Our method 90.48 90.58 89.38 95.95
Table 5.
Performance comparison for AD vs. NC (%).
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in Tables 5 and 6. The proposed approach outperformed these methods in terms of
ACC and SEN for AD diagnosis. For MCI diagnosis, our method outperforms the
other methods in SEN and AUC, and the difference with the best result is 0.21 and
1.65% for ACC and SPE, respectively. Moreover, compared with Tables 3 and 4, the
significant improvements indicate the effectiveness of the ensemble classification,
thereby explaining the multilevel features are necessary.
3. Conclusion
In this chapter, two novel methods for VOI ranking are developed to classify
brain PET images better. The first approach consists in ranking VOIs using ROC
curves and quantifies the ability of a VOI to classify HC from AD subjects thanks to
the area under curve for AUC.
The second approach which uses multilevel features is proposed to address the
PET brain classification problem. Three levels of features are extracted from PET
brain images and ranked in order to feed a SVM. Different models are trained by
using different types of features. The final decision is made through the majority
voting of different models’ outputs. According to experiments on ADNI dataset, the
proposed method can improve the performance of AD and MCI diagnosis when
compared with those state-of-the-art methods which are also developed under
FDG-PET.
To go further in computer-aided diagnosis tasks, other features like texture and
gradient computed on VOIs have to be joined to first order statistical parameters in
order to enrich information. Modern machine learning based on deep learning on
neural network will be included in our future work.
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